Entries tagged "risk arbitrage"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "risk arbitrage."

12 result(s) displayed (1 - 12 of 13)

Merz withdraws rival offer for Obagi

Winning suitor Valeant gives the FTC extra time to review the transaction. Continue reading

Posted on April 9, 2013 11:57 AM

Arbs expect another bump in Obagi battle

Merz Pharma has until Friday to counter a rival bid from Valeant. Continue reading

Posted on April 4, 2013 9:38 AM

Jitters over Focus Media fading

Lack of bad news on the SEC inquiry leads to a narrowed spread on the $3.8 billion buyout by management and a consortium of private equity partners. Continue reading

Posted on March 21, 2013 9:24 AM

All eyes on go-shop for Par Pharma

Analysts and investors think the generics maker could command a higher price. Continue reading

Posted on July 17, 2012 1:12 PM

Venoco MBO: Financing talk deflates arbs

A 'confident' letter regarding the management buyout only covers a portion of the cost. Continue reading

Posted on June 21, 2012 2:57 PM

Arbs await regulators' decision on Duke-Progress

The market worries that FERC may place more concessions on the $17.9 billion merger. Continue reading

Posted on June 11, 2012 1:46 PM

Arbs watch $400M Venoco deal

Financing is the issue for the management buyout as a deadline of sorts looms. Continue reading

Posted on June 7, 2012 10:12 AM

KSL Capital tops Apollo bid for Great Wolf

The leisure-focused private equity firm tops a previous offer from Apollo Management. Continue reading

Posted on April 9, 2012 11:10 AM

Arbs bullish on Roche-Illumina deal

The target's rejection of Roche's $5.4 billion offer prompts hopes of a bump in price. Continue reading

Posted on February 9, 2012 9:55 AM

Market bets on Southern Union-Energy Transfer

The market believes the $5.4 billion merger will clear regulators without renewed hearings in Missouri. Continue reading

Posted on January 19, 2012 3:50 PM

ConAgra's Ralcorp threat raises questions

Will ConAgra walk on Sept. 19, the deadline it imposed for Ralcorp to engage in negotiations? Continue reading

Posted on September 15, 2011 8:15 AM

Why they call it risk arb

It's been a tough couple of years. But with spreads wide, historic opportunities beckon. It's not for the faint of heart, though. Continue reading

Posted on December 12, 2008 3:14 PM

Movable Type search results powered by Fast Search